Moreover, Mcl-1 silencing in Dox-resistant MDA-MB-435 cells overexpressing P-gp, BCRP, Mcl-1, and survivin led to the loss of cell viability, suggesting that targeting Mcl-1 could serve as an alternative treatment for Dox-resistant cancer [25]. Here, MCL1 is linked to cancer.